A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
← catalyst calendarNCT06058728 · readout ≤ 12 d
Sponsored by AbbVie (industry) · ABBV — their whole pipeline →.
Phase
—
Status
Withdrawn
Study type
Observational
Enrollment
0actual
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
Company Decision
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-12-20 | actual | When the study began enrolling |
| Primary completion | Aug 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Aug 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2023-09-28 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-09-17 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Uterine Fibroids (UF)
Primary outcomes
what the primary-completion date above is the date OFPercentage of Participants with Meaningful Hair Loss
measured Up to Month 24
Time to Onset of Hair Loss
measured Up to Month 42
Changes in Patterns of Hair Loss
measured Up to Month 42
Number of Participants with Improvement in Hair Loss
measured Up to Month 42
Number of Participants with Resolution in Hair Loss
measured Up to Month 42
Time to Resolution in Hair Loss
measured Up to Month 42
Number of Participants who Discontinued Oriahnn at Reported Hair Loss
measured Up to Month 42
Permalink · ABBV's whole pipeline · Catalyst calendar · Every registered study · What changed